Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Role and Mechanisms Exploration of Histamine and Its Receptors in the Progression of Peripheral T-Cell Lymphoma

Hui Jin, Ling Wang, Yimin Ren, Zijuan Wu, Wenyu Shi, Jianyong Li

Blood (2024) 144 (Supplement 1): 4378.

https://doi.org/10.1182/blood-2024-211896

Published: 2024

Journal Articles

Targeting the Cgas-Sting Pathway Inhibits the Progression and Enhances the Chemotherapy Efficacy of Peripheral T-Cell Lymphoma

Hui Jin, Xueying Lu, Shunan Wang, Xiao Chen, Lei Cao, Zijuan Wu, Lei Fan, Jianyong Li

Blood (2023) 142 (Supplement 1): 1634.

https://doi.org/10.1182/blood-2023-185299

Published: 2023

Journal Articles

Extrachromosomal Circular DNA Drives the Progression of DLBCL through Activating the Sting Pathway

Zijuan Wu, Wei Zhang, Luqiao Wang, Lei Fan, Jianyong Li, Hui Jin

Blood (2023) 142 (Supplement 1): 1628.

https://doi.org/10.1182/blood-2023-190771

Published: 2023

Journal Articles

Investigation of the Heterogeneity Evolution and Drug Resistance Mechanism of Diffuse Large B-Cell Lymphoma Under the Treatment of a Novel HDAC Inhibitor LAQ824

Hui Jin, Luqiao Wang, Lei Fan, Zijuan Wu, Xueying Lu, Danling Gu, Wei Xu, Jianyong Li

Blood (2021) 138 (Supplement 1): 3988.

https://doi.org/10.1182/blood-2021-152006

Published: 2021

Journal Articles

Single-Cell Sequencing Technology Reveals the Heterogeneity of the Immune Microenvironment and Key Molecules of Drug Resistance in Angioimmunoblastic T-Cell Lymphoma

Hui Jin, Lei Fan, Xueying Lu, Lei Cao, Zijuan Wu, Luqiao Wang, Huayuan Zhu, Jianyong Li

Blood (2021) 138 (Supplement 1): 1322.

https://doi.org/10.1182/blood-2021-152354

Published: 2021

Journal Articles

Functional Evaluation and Mechanism Study of Sting Inhibitor H-151 in Diffuse Large B-Cell Lymphoma

Hui Jin, Luqiao Wang, Zijuan Wu, Xueying Lu, Lei Fan, Danling Gu, Lei Cao, Wei Xu, Jianyong Li

Blood (2021) 138 (Supplement 1): 2946.

https://doi.org/10.1182/blood-2021-152180

Published: 2021

Journal Articles

Novel Oncogenic Non-Coding RNA：circRIC8B Regulates Lipid Metabolism Via Mir-199b-5p /LPL Axis in Chronic Lymphocytic Leukemia

Hui Jin, Zijuan Wu, Lei Fan, Luqiao Wang, Xueying Lu, Danling Gu, Lei Cao, Jianyong Li

Blood (2021) 138 (Supplement 1): 3712.

https://doi.org/10.1182/blood-2021-151866

Published: 2021

Journal Articles

Targeting PAK1 Overcomes Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

Zijuan Wu, LEI Fan, Luqiao Wang, Hanning Tang, Yi Miao, Wei Xu, Jianyong Li, Hui Jin

Blood (2021) 138 (Supplement 1): 1546.

https://doi.org/10.1182/blood-2021-150715

Published: 2021

Journal Articles

Single-Cell RNA Sequencing Suggests Novel Drivers of Chronic Lymphocytic Leukemia Patients with Ibrutinib Resistance

Hui Jin, Zijuan Wu, Huayuan Zhu, Lei Fan, Luqiao Wang, Danling Gu, Wei Xu, Jianyong Li

Blood (2021) 138 (Supplement 1): 1539.

https://doi.org/10.1182/blood-2021-149963

Published: 2021

Journal Articles

Functional Evaluation and Mechanism Study of Kel As an Oncogenic Driver in Acute Erythroleukemia

Hui Jin, Jianyong Li, MD, Zijuan Wu, Handong Sun, Wenjie Liu, MD, Yanfeng Liu, PhD, Ming Hong, MD PhD, Sixuan Qian, Wei Xu, MD PhD

Blood (2019) 134 (Supplement_1): 1246.

https://doi.org/10.1182/blood-2019-124607

Published: 2019

Journal Articles

Circ-RPL15: A Plasma Circular RNA As Novel Oncogenic Driver to Promote Progression of Chronic Lymphocytic Leukemia

Hui Jin, Handong Sun, Zijuan Wu, Yi Xia, Jianxin Fu, MD PhD, Wei Xu, MD PhD, Jianyong Li, MD

Blood (2019) 134 (Supplement_1): 3020.

https://doi.org/10.1182/blood-2019-126610

Published: 2019

Journal Articles

Mitochondrial Genome-Derived Mc-COX2 with Novel Characteristics Predicts Prognosis of Patients with Chronic Lymphocytic Leukemia

Hui Jin, Jianyong Li, MD, Zijuan Wu, Handong Sun, Yi Xia, Jianxin Fu, MD PhD, Lei Fan, MD PhD, Wei Xu, MD PhD, Li Wang, MD

Blood (2019) 134 (Supplement_1): 4284.

https://doi.org/10.1182/blood-2019-124609

Published: 2019

Journal Articles

Pathogenesis Study of Down Syndrome Prone to Leukemia Using iPSCs from Trisomy 21 Patients

Hui Jin, PhD, Zijuan Wu, Handong Sun, Jianyong Li, MD PhD

Blood (2018) 132 (Supplement 1): 5085.

https://doi.org/10.1182/blood-2018-99-120320

Published: 2018

NARROW

Role and Mechanisms Exploration of Histamine and Its Receptors in the Progression of Peripheral T-Cell Lymphoma

Targeting the Cgas-Sting Pathway Inhibits the Progression and Enhances the Chemotherapy Efficacy of Peripheral T-Cell Lymphoma

Extrachromosomal Circular DNA Drives the Progression of DLBCL through Activating the Sting Pathway

Investigation of the Heterogeneity Evolution and Drug Resistance Mechanism of Diffuse Large B-Cell Lymphoma Under the Treatment of a Novel HDAC Inhibitor LAQ824

Single-Cell Sequencing Technology Reveals the Heterogeneity of the Immune Microenvironment and Key Molecules of Drug Resistance in Angioimmunoblastic T-Cell Lymphoma

Functional Evaluation and Mechanism Study of Sting Inhibitor H-151 in Diffuse Large B-Cell Lymphoma

Novel Oncogenic Non-Coding RNA：circRIC8B Regulates Lipid Metabolism Via Mir-199b-5p /LPL Axis in Chronic Lymphocytic Leukemia

Targeting PAK1 Overcomes Resistance to Ibrutinib in Chronic Lymphocytic Leukemia

Single-Cell RNA Sequencing Suggests Novel Drivers of Chronic Lymphocytic Leukemia Patients with Ibrutinib Resistance

Functional Evaluation and Mechanism Study of Kel As an Oncogenic Driver in Acute Erythroleukemia

Circ-RPL15: A Plasma Circular RNA As Novel Oncogenic Driver to Promote Progression of Chronic Lymphocytic Leukemia

Mitochondrial Genome-Derived Mc-COX2 with Novel Characteristics Predicts Prognosis of Patients with Chronic Lymphocytic Leukemia

Pathogenesis Study of Down Syndrome Prone to Leukemia Using iPSCs from Trisomy 21 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only